ADC Therapeutics's total assets for Q4 2024 were $321.98M, a decrease of -7.76% from the previous quarter. ADCT total liabilities were $524.62M for the fiscal quarter, a 0.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.